MAP4K4 inhibition promotes survival of human stem cell derived cardiomyocyte and reduces infarct size in vivo




COUNTER-compliant statistics provided by IRUS-UK.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.